The importance of assessing the self-reported impact of COVID-19 on clinician mental health

Kapila, Ayush K; Ram, A. Ganesh; D'Uva, Lorenzo; Farid, Yasser; Talib, M. Abu

doi:10.1016/j.ejpsy.2020.06.002

Cited by 3 publications

(8 citation statements)

References 5 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Indeed, increased exposure to COVID-19 cases has been shown to fuel stress, anxiety and depression among healthcare providers [24]. Therefore, it is understandable that mental and brain disorders during the COVID-19 pandemic may be more frequent among healthcare workers in Europe, America, Asia [3,6,[25][26][27], but also in neighbouring Nigeria [28] which has more than thrice the number of COVID-19 cases in Cameroon [1]. It is worth noting that another survey previously conducted among healthcare workers in Cameroon during the COVID-19 pandemic found a prevalence of depression of 42.8% using the Hospital Anxiety and Depression scale (HADS) [29], compared to 8.5% in our study.…”

Section: Discussionmentioning

confidence: 99%

“…Scores of 10 or above are often considered as an indication of a likely depressive disorder, as previously validated in a Cameroonian study population [17]. Other cut-offs have been proposed to further discriminate the severity of depressive symptoms: cut-off scores of 0-4 = none/minimal; 5-9 = mild; 10-14 = moderate; 15-19 = moderately severe; 20-27 = severe [3,15].…”

Section: Study Tools and Proceduresmentioning

confidence: 99%

“…Besides the biological (and sometimes fatal) damages caused by the virus, the COVID-19 pandemic has been associated with signi cant psychological and social distress around the globe. Indeed, studies conducted during the COVID-19 pandemic have revealed high levels of stress, anxiety and depressive disorders among the general population [2], as well as speci c populations: healthcare workers and their families [3][4][5], military personnel [6], and COVID-19 survivors [7]. The socio-economic consequences of the strict lockdown measures implemented in many countries further exacerbated the nancial insecurities of the population with adverse effects on their psychological and social well-being, leading to suicide in some cases [8].…”

Section: Introductionmentioning

confidence: 99%

See 2 more Smart Citations

Fear and Depression during the COVID-19 Outbreak in Cameroon: A Nation-wide Observational Study

Fodjo

Ngarka

Njamnshi

et al. 2021

Preprint

View full text Add to dashboard Cite

Background: The COVID-19 pandemic has been associated with significant psychological and social distress worldwide. We investigated fear and depression among adults in Cameroon during different phases of the COVID-19 outbreak.Methods: An online survey was conducted in Cameroon from June–December 2020 using a structured questionnaire. Socio-demographic data and information regarding COVID-19 history were obtained. Fear and depressive symptoms were assessed using the Fear of COVID-19 score (FCV-19S) and the Patient Health Questionnaire (PHQ-9), respectively. Responses were clustered in weeks to better appreciate their evolution over time.Results: Overall, 7381 responses from all ten regions of Cameroon were analysed (median age: 30 years, 73.3% male). The prevalence of depression (PHQ-9 score ≥10) was 8.4%, and that of high fear of COVID-19 (FCV-19S scores ≥19) was 57.4%. These rates were similar across genders, age-groups, and region of residence. While mean weekly PHQ-9 scores remained fairly stable throughout the study period (range: 2.53 – 3.21; p=0.101), mean FCV-19S scores were highest during the early weeks but decreased significantly thereafter (from 20.31 to 18.34; p <0.001). Multivariate analyses revealed that having a postgraduate degree, a history of quarantine, flu-like symptoms during the past 14 days, and higher FCV-19S scores were associated with more severe depressive symptoms, while obtaining COVID-19 information from various sources reduced the odds for depression. Conclusion: Depression amidst the COVID-19 crisis is less prevalent in Cameroon than in other countries. Prompt and widespread dissemination of adequate COVID-19 information may reduce the risks for depression by dispelling fear and anxiety among Cameroonians.

show abstract

Section: Discussionmentioning

confidence: 99%

Section: Study Tools and Proceduresmentioning

confidence: 99%

Section: Introductionmentioning

confidence: 99%

See 1 more Smart Citation

Fear and Depression during the COVID-19 Outbreak in Cameroon: A Nation-wide Observational Study

Fodjo

Ngarka

Njamnshi

et al. 2021

Preprint

View full text Add to dashboard Cite

show abstract

“…Scores of 10 or above are often considered as an indication of a likely depressive disorder, as previously validated in a Cameroonian study population [19]. Other cut-offs have been proposed to further discriminate the severity of depressive symptoms: cut-off scores of 0-4 = none/minimal; 5-9 = mild; 10-14 = moderate; 15-19 = moderately severe; 20-27 = severe [3,17].…”

Section: Study Tools and Proceduresmentioning

confidence: 99%

“…Besides the biological (and sometimes fatal) damages caused by the virus, the COVID-19 pandemic has been associated with significant psychological and social distress around the globe. Indeed, studies conducted during the COVID-19 pandemic have revealed high levels of stress, anxiety and depressive disorders among the general population [2], as well as specific populations: healthcare workers and their families [3][4][5], military personnel [6], and COVID-19 survivors [7]. Available data suggests that women and younger individuals are more affected by psychosocial symptoms during the COVID-19 pandemic [8,9].…”

Section: Introductionmentioning

confidence: 99%

Fear and depression during the COVID-19 outbreak in Cameroon: a nation-wide observational study

Fodjo

Ngarka²,

Njamnshi³

et al. 2021

BMC Psychiatry

View full text Add to dashboard Cite

Background The COVID-19 pandemic has been associated with significant psychological and social distress worldwide. We investigated fear and depression among adults in Cameroon during different phases of the COVID-19 outbreak. Methods An online survey was conducted in Cameroon from June–December 2020 using a structured questionnaire. Socio-demographic data and information regarding COVID-19 history were obtained. Fear and depressive symptoms were assessed using the Fear of COVID-19 score (FCV-19S) and the Patient Health Questionnaire (PHQ-9), respectively. Responses were clustered in weeks to better appreciate their evolution over time. Results Overall, 7381 responses from all ten regions of Cameroon were analysed (median age: 30 years, 73.3% male). The prevalence of depression (PHQ-9 score ≥ 10) was 8.4%, and that of high fear of COVID-19 (FCV-19S scores ≥19) was 57.4%. These rates were similar across genders, age-groups, and region of residence. While mean weekly PHQ-9 scores remained fairly stable throughout the study period (range: 2.53–3.21; p = 0.101), mean FCV-19S scores were highest during the early weeks but decreased significantly thereafter (from 20.31 to 18.34; p < 0.001). Multivariate analyses revealed that having a postgraduate degree, a history of quarantine, flu-like symptoms during the past 14 days, and higher FCV-19S scores were associated with more severe depressive symptoms, while obtaining COVID-19 information from various sources reduced the odds for depression. Conclusion Depression amidst the COVID-19 crisis is less prevalent in Cameroon than in other countries. Prompt and widespread dissemination of adequate COVID-19 information may reduce the risks for depression by dispelling fear and anxiety among Cameroonians.

show abstract

Case Report of Two Patients With COVID-19 and Sacral Pressure Injuries Associated with Pyoderma Gangrenosum

Elkhatib

Giunta

Hanssens

et al. 2021

Adv Skin Wound Care

View full text Add to dashboard Cite

During the COVID-19 pandemic, an increasing number of patients have been admitted to the ICU with severe respiratory complications requiring prolonged supine positioning. Recently, many case reports have been published regarding dermatologic manifestations associated with COVID-19. However, there is little information about the clinical features of these manifestations. Pyoderma gangrenosum (PG) is an ulcerative noninfectious inflammatory disease of the skin. In at least 50% of the cases, the etiology is unknown. Nevertheless, PG is associated with many systemic diseases. In this article, the authors report two critically ill patients with COVID-19 who developed sacral ulcers during their recovery in the ICU. These ulcers had an atypical course and were exacerbated by surgical debridements. Accordingly, providers suspected PG, which was confirmed by the clinical evolution of the ulcers and biopsies taken from the wounds. To the best of the authors’ knowledge, no previous articles have reported sacral pressure injuries associated with PG in patients with COVID-19. Providers should suspect PG in patients with COVID-19 who develop nonhealing pressure injuries.

show abstract

The importance of assessing the self-reported impact of COVID-19 on clinician mental health

Cited by 3 publications

References 5 publications

Fear and Depression during the COVID-19 Outbreak in Cameroon: A Nation-wide Observational Study

Fear and Depression during the COVID-19 Outbreak in Cameroon: A Nation-wide Observational Study

Fear and depression during the COVID-19 outbreak in Cameroon: a nation-wide observational study

Case Report of Two Patients With COVID-19 and Sacral Pressure Injuries Associated with Pyoderma Gangrenosum

Contact Info

Product

Resources

About